110 related articles for article (PubMed ID: 28986883)
1. Surface Markers for the Identification of Cancer Stem Cells.
Gopalan V; Islam F; Lam AK
Methods Mol Biol; 2018; 1692():17-29. PubMed ID: 28986883
[TBL] [Abstract][Full Text] [Related]
2. Surface Markers for the Identification of Cancer Stem Cells.
Pronoy TUH; Islam F; Gopalan V; Lam AK
Methods Mol Biol; 2024; 2777():51-69. PubMed ID: 38478335
[TBL] [Abstract][Full Text] [Related]
3. Targeting glioblastoma stem cells: cell surface markers.
He J; Liu Y; Lubman DM
Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566
[TBL] [Abstract][Full Text] [Related]
4. Liver cancer stem cell markers: Progression and therapeutic implications.
Sun JH; Luo Q; Liu LL; Song GB
World J Gastroenterol; 2016 Apr; 22(13):3547-57. PubMed ID: 27053846
[TBL] [Abstract][Full Text] [Related]
5. Stem cells in normal development and cancer.
D'Angelo RC; Wicha MS
Prog Mol Biol Transl Sci; 2010; 95():113-58. PubMed ID: 21075331
[TBL] [Abstract][Full Text] [Related]
6. ALDH1 as a functional marker of cancer stem and progenitor cells.
Douville J; Beaulieu R; Balicki D
Stem Cells Dev; 2009; 18(1):17-25. PubMed ID: 18573038
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cell markers: premises and prospects.
Murar M; Vaidya A
Biomark Med; 2015; 9(12):1331-42. PubMed ID: 26612591
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cell markers as potential targets for epithelial cancers.
Madka V; Rao CV
Indian J Exp Biol; 2011 Nov; 49(11):826-35. PubMed ID: 22126013
[TBL] [Abstract][Full Text] [Related]
11. Research progress and prospects of markers for liver cancer stem cells.
Zhu CP; Wang AQ; Zhang HH; Wan XS; Yang XB; Chen SG; Zhao HT
World J Gastroenterol; 2015 Nov; 21(42):12190-6. PubMed ID: 26576103
[TBL] [Abstract][Full Text] [Related]
12. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment.
Islam F; Gopalan V; Smith RA; Lam AK
Exp Cell Res; 2015 Jul; 335(1):135-47. PubMed ID: 25967525
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell marker glycosylation: Nature, function and significance.
Mallard BW; Tiralongo J
Glycoconj J; 2017 Aug; 34(4):441-452. PubMed ID: 28624993
[TBL] [Abstract][Full Text] [Related]
14. [Cancer stem cell markers and their prognostic value].
Puchinskaya MV
Arkh Patol; 2016; 78(2):47-54. PubMed ID: 27340717
[TBL] [Abstract][Full Text] [Related]
15. Markers in normal and cancer stem cells.
Natarajan TG; FitzGerald KT
Cancer Biomark; 2007; 3(4-5):211-31. PubMed ID: 17917151
[TBL] [Abstract][Full Text] [Related]
16. CD133 as a marker for cancer stem cells: progresses and concerns.
Wu Y; Wu PY
Stem Cells Dev; 2009 Oct; 18(8):1127-34. PubMed ID: 19409053
[TBL] [Abstract][Full Text] [Related]
17. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.
Grosse-Gehling P; Fargeas CA; Dittfeld C; Garbe Y; Alison MR; Corbeil D; Kunz-Schughart LA
J Pathol; 2013 Feb; 229(3):355-78. PubMed ID: 22899341
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of cancer stem cells in renal cell carcinoma.
Lucarelli G; Galleggiante V; Rutigliano M; Vavallo A; Ditonno P; Battaglia M
Urologia; 2015; 82(1):46-53. PubMed ID: 25451878
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells.
Hsieh CH; Hsiung SC; Yeh CT; Yen CF; Chou YW; Lei WY; Pang ST; Chuang CK; Liao SK
Oncotarget; 2017 Feb; 8(9):15593-15609. PubMed ID: 28121626
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
